Holger Wesche, Chief Scientific Officer at Harpoon Therapeutics, Inc. (HARP), sold 10,000 shares at $16.19 ($163K) on 2020-10-01, disclosed to the SEC on 2020-10-05.
Open-market sale of $163k HARP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.19 | 9,000 | $146K | 89.5% |
| 2 | $17.03 | 1,000 | $17K | 10.5% |
| Total | $16.27 avg | 10,000 | $163K | 100% |
| Filing → |
| HARP | SELL | 2021-01-06 | $314K | — | Filing → |
| HARP | SELL | 2020-07-02 | $162K | — | Filing → |
| HARP | SELL | 2020-05-13 | $20K | — | Filing → |